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Retinal nerve fiber layer (RNFL) thickness is reduced in Alzheimer’s patients. However, 
whether it is associated with early evolution of cognitive function is unknown. Within 
427 participants from the Three-City-Alienor longitudinal population-based cohort, we 
explored the relationship between peripapillary RNFL thicknesses and the evolution 
of cognitive performance. RNFL was assessed at baseline by spectral domain optical 
coherence tomography; cognitive performances were assessed at baseline and at 
2 years, with the Mini–Mental State Examination, the Isaacs’ set test, and the Free and 
Cued Selective Reminding Test (FCSRT). Multivariate linear mixed models were per-
formed. The RNFL was not associated with initial cognitive performance. Nevertheless, 
a thicker RNFL was significantly associated with a better cognitive evolution over time in 
the free delayed recall (p = 0.0037) and free + cued delayed recall (p = 0.0043) scores of 
the FCSRT, particularly in the temporal, superotemporal, and inferotemporal segments. 
No associations were found with other cognitive tests. The RNFL was associated with 
changes in scores that assess episodic memory. RNFL thickness could reflect a higher 
risk of developing cognitive impairment over time.
Keywords: retinal nerve fiber layer, episodic memory, cognition, elderly, optical coherence tomography
inTrODUcTiOn
Alzheimer’s disease (AD) is associated with brain neurodegeneration, particularly in the medial 
temporal area, which leads to cognitive decline and dementia. These lesions occur several years 
before the clinical phase of dementia (1, 2). Detection of this neurodegenerative process at an early 
stage could allow prediction of cognitive decline in subsequent years.
The retina and brain are intimately linked as a result of common embryonic origin. The eye is 
a sensory organ that is truly part of the central nervous system, with neuronal cells that could be 
susceptible to degeneration, directly or indirectly. Thus, the condition of nerve fibers in the eye could 
reflect the condition of nerve fibers in the brain (3). Spectral domain optical coherence tomography 
(SD-OCT) allows easy and accurate evaluation of the peripapillary retinal nerve fiber layer (RNFL), 
by measuring the thickness of this layer containing ganglion cell axons in a circle around the optic 
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nerve. This RNFL could thus enable evaluation of neurodegenera-
tion in mild cognitive impairment (MCI) and AD pathology (4).
Abnormality in RNFL thickness has been described in 
several neurodegenerative conditions, in particular multiple 
sclerosis, AD, and Parkinson’s disease (5–7). Regarding MCI 
and/or AD, several previous studies have demonstrated 
reduced RNFL thickness compared to that of a healthy control 
population, initially in histological studies (8) and then in OCT 
studies (4, 9, 10); these studies were, however, mostly cross-
sectional case–control studies. Additionally, we previously 
found an association between glaucoma pathology, which 
has reduced RNFL thickness, and the occurrence of dementia 
3 years later (11). However, except for one study with a small 
sample (12), the association between RNFL and the evolution 
of cognitive function has not yet been studied in a general 
elderly population.
Our study aims to explore the relationship between peripapil-
lary RNFL thickness measured by SD-OCT and the evolution of 
cognitive function in several cognitive domains measured over a 
2-year period in the elderly population.
MaTerials anD MeThODs
study Population
The Three-City (3C) study is a prospective population-based 
cohort, which aims to estimate the risk of dementia and cogni-
tive impairment attributable to vascular factors. At baseline 
(1999–2001), 9,294 community-dwelling French adults aged 
≥65 years in three French cities (Bordeaux, Dijon, Montpellier) 
were enrolled, including 2,104 from Bordeaux. The methodology 
has been described elsewhere (13). Data regarding sociodemo-
graphic characteristics, lifestyle, physical and mental health, 
medications, disability, and cognitive functions were assessed at 
baseline and subsequently 2, 4, 7, 10, and 12 years later. At the 
7-year follow-up (in 2006–2008), 963 participants from Bordeaux 
agreed to participate to the Alienor study (Antioxydants, Lipides 
Essentiels, Nutrition et maladies OculaiRes), consisting of an 
ophthalmological examination (14). These participants were 
then followed-up every two years with eye examinations con-
current with cognitive evaluations. In 2009–2010, a SD-OCT 
examination of the optic nerve was included in the eye examina-
tion; 624 participants were evaluated. Our population consists of 
participants with (i) valid RNFL measurements at that time, i.e., 
without any segmentation problem and without ocular pathol-
ogy that could influence RNFL measurement (vitreomacular 
traction, myelinated retinal nerve fibers, peripapillary choroidal 
neovascularization, or myopic chorioretinopathy), (ii) concur-
rent cognitive evaluations, (iii) without prevalent dementia 
in 2009–2010, and (iv) without missing data for confounders. 
Because glaucoma is a degenerative disease of the optic nerve 
that could have common pathophysiological mechanisms with 
AD, participants with this disease were retained in the study 
population, and glaucoma was included as a covariate in the 
analyses (11). Finally, participants without cognitive evaluation 
at 2 years were excluded, with thus 427 participants considered 
for the present study (Figure 1).
Approvals were obtained from the Ethical Committee Sud-
Ouest et Outre-Mer III for the Alienor study and from the Ethical 
Committee of the University Hospital of Kremlin-Bicêtre and 
Sud-Mediterranée III for the 3C study. All participants signed 
an informed consent.
cognitive assessment
At each follow-up visit, trained psychologists assessed the cogni-
tive function of each participant during face-to-face visits using 
the Mini–Mental State Examination (MMSE) (15), the Isaacs’ 
set test at 30 s (16) and the Free and Cued Selective Reminding 
Test (FCSRT) (17). After the neuropsychological examination, 
participants suspected of having dementia were visited by a neu-
rologist or a geriatric specialist, to confirm the diagnosis. Finally, 
an independent committee of neurologists reviewed all potential 
cases of dementia with all available information in order to obtain 
a consensus on the diagnosis, according to the DSM-IV criteria 
for dementia (18). For this study, we analyzed RNFL measure-
ment in relation to cognitive performance assessed at the same 
baseline time as RNFL and 2 years later.
The MMSE is a composite scale from 0 to 30 points that 
evaluates the global cognitive state. The Isaacs’ set test evaluates 
categorical verbal fluency by measuring the ability to generate 
word lists from four semantic categories (animals, fruits, colors, 
and cities) in 30 s. Finally, the FCSRT evaluates episodic memory 
using a list of 16 words belonging to 16 semantic categories. 
This test assesses episodic memory processes by controlling the 
encoding and retrieval conditions. It starts with an initial phase 
of categorical semantic learning, followed by three notation 
steps (immediate recall, three free/cued recalls, and delayed free/
cued recalls). We used four variables in our study: the three free 
recalls score, the added score of three free plus cued recalls, the 
delayed free recalls, and finally the added score of delayed free plus 
cued recalls. Other details of the procedure have been previously 
described (19). None of the staff involved in cognitive testing had 
access to ophthalmologic data.
Ophthalmologic assessments
SD-OCT Measures
The OCT examination was performed using SPECTRALIS 
(Software Version 5.4.7.0; Heidelberg Engineering, Heidelberg, 
Germany) without pupil dilation by one experienced technician. 
The device acquisition rate of OCT images was 40,000 A-scans/s. 
The OCT provides an automatic real-time (ART) function that 
adjusts for eye movement and increases image quality. Details 
of our OCT measures have been previously described (20). The 
peripapillary RNFL thickness was acquired using the following 
conditions (14): resolution mode: high speed; circle diameter: 
3.5 mm; size X: 768 pixels (10.9 mm); size Z: 496 pixels (1.9 mm); 
scaling X: 14.14 lm/pixel; scaling Z: 3.87 lm/pixel; and ART mode: 
16 images. The minimum reliable value of global RNFL thickness 
was retained for analysis when the measure was present in both 
eyes; otherwise, data from the eye with the only reliable value were 
retained. RNFL thicknesses in the six segments measured by the 
device (superotemporal, temporal, inferotemporal, inferonasal, 
nasal, and superonasal) were retained for the same eye (Figure 2).
FigUre 1 | Flow chart of the population. RNFL, retinal nerve fiber layer.
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Other Ophthalmologic Variables
As previously described (14), the diagnosis of glaucoma was 
established according to the classification proposed by Foster 
et al. (21). Cataract surgery was assessed during eye examination. 
Optic disc size (vertical disc diameter) was measured using optic 
disc photography in duplicate by two trained graders and by a 
glaucoma specialist if there was inconsistency between the first 
two interpretations. Finally, axial length was measured during a 
subsequent visit in a subsample of participants using non-contact 
partial coherence laser interferometry (IOL Master; Carl Zeiss 
Meditec AG, Jena, Germany). Five measurements were taken per 
eye, and the mean was calculated. None of the staff involved in 
eye examination had access to the cognitive data.
Other Variables
The following covariates were assessed: age, sex, education level 
(elementary school, secondary school vs higher level), the pres-
ence of Apolipoprotein ε4 allele and diabetes (antidiabetic treat-
ment and/or a fasting glucose level ≥7 mmol/L or a non-fasting 
glucose level ≥11 mmol/L).
Data analysis
Baseline characteristics of the study sample were first described. 
To study the relationship between the RNFL thickness and the 
cognitive scores at baseline and cognitive change over time we 
built linear mixed models to account for the correlations due to 
repeated cognitive measures (22). We first analyzed the relation-
ship between global RNFL thickness (continuous variable) and 
each cognitive test to avoid multiplicity of statistical analyses. We 
further analyzed all six RNFL segments only when the result was 
significant for global RNFL. Due to ceiling and floor effects and 
curvilinearity (unequal interval scaling) for MMSE and FCSRT 
scores, we used a previously published procedure that corrects the 
metrological properties to normalize the score distributions (23). 
First, models were adjusted for age, sex, time, education level, 
ApoE4, diabetes, cataract surgery, optic disc size, and glaucoma 
in multivariable linear mixed models (Model A). The interaction 
between each variable and time was systematically tested and 
retained in the model when p < 0.10. Next, given the knowledge 
that RNFL thickness decreases with increasing axial length (24), 
a second model (Model B) was built including axial length as a 
covariate; this measure was available for only a subset (n = 204) of 
the study population. Sensitivity analyses excluding participants 
with glaucoma were performed. In complementary analyses, we 
re-ran the analyses for global RNFL considering RNFL as a binary 
variable, according to the classification provided by the Spectralis 
software: outside normal limits (lowest 1% of the distribution), 
borderline (bottom 1–5% of the distribution), and within normal 
(above 5%) based on the age-matched comparison with an inter-
nal normative database of 201 healthy eyes of Caucasian patients. 
Thus, we analyzed the evolution of cognitive performance for 
participants with borderline value or value outside normal limits, 
compared to value within normal.
The normalization procedure of cognitive scores was per-
formed using R software (version 2.14.1, 2011© The R Foundation 
for Statistical Computing). All other statistical procedures were 
performed using SAS software (version 9.3, SAS Institute Inc., 
Cary, NC, USA).
FigUre 2 | global and six segments thicknesses of rnFl, n = 427. T, temporal segment; ST, superotemporal segment; SN, superonasal segment; N, nasal 
segment; IN, inferonasal segment; IT, inferotemporal segment.
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resUlTs
Population characteristics of the 427 participants are described in 
Table 1. The mean age was 81.6 (SD: 4.2) years and 62.3% were 
women. The mean global RNFL thickness was 86.8 μm (SD: 13.7). 
As expected, the inferotemporal (122.3 μm) and superotemporal 
(115.9 μm) segments were thickest. Mean MMSE score at baseline 
was 27.8 (SD: 1.9). Cognitive performance significantly declined 
over the 2-year follow-up, irrespective of the test considered 
(Table S1 in Supplementary Material).
The global RNFL was not associated with initial cognitive 
performance regardless of cognitive test considered (Table  2). 
Global RNFL was not associated with cognitive evolution based 
on the MMSE or the Isaacs’ set test at follow-up (RNFL × time 
term). However, global RNFL was associated with the two FCSRT 
scores of delayed recall. Specifically, a thicker global RNFL was 
associated with a lower decline of delayed free recall (β = 0.015; 
95% CI, 0.005 to 0.025; p = 0.004 for 1 μm RNFL thickness) and 
delayed free plus cued recalls (β = 0.007; 95% CI, 0.002 to 0.011; 
p = 0.004) (Table 2, model A).
These associations remained unchanged after additional 
adjustment for axial length in the subset which had this measure 
(Table  2, model B). Mean delayed FCSRT scores, at baseline 
and at the follow-up, are graphically represented in Figure S1 in 
Supplementary Material according to baseline RNFL value.
For FCSRT scores showing significant association with 
global RNFL, the relationships with each of the six RNFL seg-
ments were analyzed (Table 3). The temporal segments had the 
strongest association with the two FCSRT delayed recall scores. 
Thicker RNFL of the temporal, inferotemporal, and superotem-
poral segments was significantly associated with a lower decline 
in the delayed free recall score during follow-up (β = 0.013; 95% 
CI, 0.003 to 0.023; p = 0.011; β = 0.007; 95% CI, 0.002 to 0.012; 
p =  0.005; and β =  0.007; 95% CI, 0.002 to 0.013; p =  0.013, 
respectively) in model A. The same trends were observed in 
model B after additional adjustment for axial length; although, 
the associations were only borderline significant for the tem-
poral and inferotemporal segments. Surprisingly, the temporal 
segment also showed an association with a lower initial score 
(β = −0.029; 95% CI, −0.054 to −0.005; p =  0.020), but this 
association was no longer significant after adjustment for axial 
length.
For delayed free plus cued recalls, the decline over the follow-up 
was also associated with RNFL thickness in the “temporal side”; 
this association was significant only for the inferotemporal seg-
ment in model A (β = 0.003; 95% CI, 0.0003 to 0.005; p = 0.025). It 
was also significant for the three temporal segments in the subset 
with axial length measured (Model B; β = 0.009; 95% CI, 0.002 
to 0.016; p = 0.010; β = 0.005; 95% CI, 0.002 to 0.008; p < 0.001; 
and β = 0.005; 95% CI; 0.001 to 0.009; p = 0.010, for temporal, 
inferotemporal and superotemporal segments, respectively). 
Additionally, thicker RNFL of the nasal segment was also associ-
ated with lower decline of the cognitive score (Models A and B). 
Surprisingly, in model B, an association was also demonstrated 
between inferotemporal segment thickness and a lower initial 
score (β = −0.009; 95% CI, −0.017 to −0.002; p = 0.011).
Results were globally unchanged in sensitivity analyses 
excluding participants with glaucoma.
Table 2 | initial differences and evolution over time of the 
neuropsychological tests according to the global thickness of the rnFl.
Model a (n = 427) Model b (n = 204)
β (95% ci) p β (95% ci) p
MMse
RNFL −0.006  
(−0.020 to 0.007)
0.358 0.008  
(−0.012 to 0.027)
0.434
RNFL × time 0.004  
(−0.003 to 0.011)
0.234 0.002  
(−0.007 to 0.011)
0.692
isaacs’ set test at 30″
RNFL −0.001  
(−0.069 to 0.067)
0.986 0.004  
(−0.090 to 0.098)
0.933
RNFL × time 0.001  
(−0.020 to 0.023)
0.910 0.017  
(−0.013 to 0.046)
0.264
FcsrT
Score of three 
free recallsa
RNFL 0.011  
(−0.004 to 0.025)
0.153 0.015  
(−0.005 to 0.036)
0.138
RNFL × time 0.001  
(−0.004 to 0.007)
0.609 0.004  
(−0.004 to 0.011)
0.342
Score of three 
free plus cued 
recallsb
RNFL 0.010  
(−0.001 to 0.021)
0.089 0.013  
(−0.003 to 0.029)
0.109
RNFL × time −0.001  
(−0.006 to 0.004)
0.662 −0.002  
(−0.008 to 0.005)
0.589
Score of delayed 
free recallc
RNFL −0.002  
(−0.028 to 0.024)
0.862 −0.003  
(−0.040 to 0.034)
0.869
RNFL × time 0.015  
(0.005 to 0.025)
0.004 0.017  
(0.003 to 0.030)
0.014
Score of delayed 
free plus cued 
recalls
RNFL −0.006  
(−0.017 to 0.004)
0.253 −0.010  
(−0.024 to 0.005)
0.195
RNFL × time 0.007  
(0.002 to 0.011)
0.004 0.011  
(0.005 to 0.017)
<0.001
Model A adjusted for: time, age, interaction age/time, sex, school level, Apolipoprotein 
ε4, diabetes, diameter of optic nerve head, cataract surgery, and glaucoma.
Model B adjusted for: the same A-model with additional adjustment for axial length (AL) 
measure.
aAdditional adjustment for the interaction sex/time in model A and B.
bAdditional adjustment for the interaction diabetes/time in model A and B and the 
interaction AL/time in model B.
cAdditional adjustment for the interaction Apolipoprotein ε4/time in model A and B.
MMSE, Mini–Mental State Examination; FCSRT, Free and Cued Selective Reminding 
Test; RNFL, retinal nerve fiber layer.
Bold p-value indicates p < 0.05.
Table 1 | characteristics of the study population at inclusion, N = 427.
Mean or n sD or %
sociodemographic, medical, and ophthalmological characteristics
Age (years), mean (SD) 81.6 4.2
Female, n (%) 266 62.3
Educational level, n (%)
Elementary school 33 7.7
Secondary school 198 46.4
Higher level 196 45.9
Apolipoprotein ε4, n (%) 72 16.9
Diabetes, n (%) 44 10.3
Glaucoma, n (%) 26 6.1
Cataract surgery (with or without implant), n (%) 212 49.6
Vertical diameter of the ONH (in mm), mean (SD) 2.0 0.2
Axial lengtha (in mm), mean (SD) 23.4 1.2
cognitive assessment tests at baselineb
MMSE, mean (SD) 27.8 1.9
Isaacs’ set test at 30″, mean (SD) 45.1 9.7
FCSRT, mean (SD)
Score of three free recalls 26.1 7.1
Score of three free plus cued recalls 45.1 4.6
Score of delayed free recall 10.4 3.1
Score of delayed free plus cued recalls 15.3 1.6
rnFl assessment measures
Global RNFL thickness (in μm), mean (SD) 86.8 13.7
Global RNFL classification,c n (%)
Within normal limits 297 69.6
Borderline 54 12.6
Outside normal limits 76 17.8
Segments thickness (in μm), mean (SD)
Superotemporal 115.9 23.5
Temporal 67.2 13.4
Inferotemporal 122.3 27.1
Inferonasal 97.3 24.4
Nasal 66.2 16.4
Superonasal 91.4 23.3
MMSE, Mini–Mental State Examination; FCSRT, Free and Cued Selective Reminding 
Test; RNFL, retinal nerve fiber layer.
Missing data: Isaacs’ set test at 30″ (n = 5); all FCSRT scores (n = 30).
aMeasure obtained from 204 participants.
bScores for the cognitive assessment performed at baseline, at the same time as RNFL 
measurement, are presented here.
cClassification provided by the Spectralis software: outside normal limits (lowest 1% of 
the distribution), borderline (bottom 1–5% of the distribution) and within normal (above 
5%) based on the age-matched comparison with an internal normative database 
of 201 healthy eyes of Caucasian patients. For each participant, the worse eye is 
considered here.
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Similar results were also observed in complementary analyses. 
Participants classified as borderline (12.6%) or outside normal 
limits (17.8%) for their global RNFL value (i.e., with thin RNFL) 
according to the Spectralis software classification had a higher 
decline for the two FCSRT scores of delayed recall (β = −0.40; 
95% CI, −0.71 to −0.10; p =  0.009 for delayed free recall and 
β = −0.20; 95% CI, −0.34 to −0.05; p = 0.007 for delayed free plus 
cued recalls).
DiscUssiOn
We found that, whereas global RNFL thickness was not associated 
with initial cognitive scores, a thicker RNFL was associated with 
a lower decline of cognitive performances based on the delayed 
recall scores of the FCSRT. None of the other cognitive functions 
were associated with RNFL thickness. These findings suggest that 
reduced RNFL thickness may reflect a higher risk of episodic 
memory deterioration over time.
The reduction of RNFL thickness in patients with MCI and/or 
AD, compared to controls, has been previously reported in several 
studies (4, 9, 10). These previous studies support a systematic and 
cumulative reduction of the RNFL thickness with the progression 
of the cognitive impairment. The association between RNFL and 
cognition at an earlier stage is largely unknown; yet, cognitive 
decline is a very long process (25). Thus, our results may fit into 
a very early stage of cognitive impairment. Moreover, our study 
Table 3 | initial differences and evolution over time of the FcsrT score of delayed free recall and delayed free plus cued recalls according to the 
segments of the rnFl.
Model a (n = 427) Model b (n = 204)
β (95% ci) p β (95% ci) p
Delayed free recalla
Superotemporal −0.009 (−0.024 to 0.006) 0.223 −0.009 (−0.031 to 0.012) 0.402
Superotemporal × time 0.007 (0.002 to 0.013) 0.013 0.012 (0.004 to 0.020) 0.003
Temporal −0.029 (−0.054 to −0.005) 0.020 −0.024 (−0.060 to 0.011) 0.183
Temporal × time 0.013 (0.003 to 0.023) 0.011 0.013 (−0.002 to 0.027) 0.080
Inferotemporal −0.006 (−0.020 to 0.007) 0.343 −0.009 (−0.028 to 0.010) 0.340
Inferotemporal × time 0.007 (0.002 to 0.012) 0.005 0.006 (−0.0004 to 0.013) 0.067
Inferonasal 0.009 (−0.005 to 0.023) 0.192 0.005 (−0.014 to 0.024) 0.578
Inferonasal × time 0.005 (−0.001 to 0.011) 0.084 0.006 (−0.002 to 0.013) 0.142
Nasal 0.020 (−0.00002 to 0.040) 0.050 0.023 (−0.005 to 0.052) 0.112
Nasal × time 0.005 (−0.003 to 0.013) 0.232 0.005 (−0.006 to 0.017) 0.351
Superonasal −0.003 (−0.018 to 0.011) 0.648 −0.008 (−0.028 to 0.013) 0.457
Superonasal × time 0.004 (−0.002 to 0.010) 0.169 0.006 (−0.002 to 0.014) 0.143
Delayed free plus cued recalls
Superotemporal −0.005 (−0.011 to 0.001) 0.112 −0.005 (−0.014 to 0.003) 0.232
Superotemporal × time 0.002 (−0.001 to 0.005) 0.108 0.005 (0.001 to 0.009) 0.010
Temporal −0.009 (−0.019 to 0.001) 0.089 −0.012 (−0.026 to 0.002) 0.096
Temporal × time 0.005 (−0.00003 to 0.009) 0.051 0.009 (0.002 to 0.016) 0.010
Inferotemporal −0.005 (−0.010 to 0.001) 0.092 −0.009 (−0.017 to −0.002) 0.011
Inferotemporal × time 0.003 (0.0003 to 0.005) 0.025 0.005 (0.002 to 0.008) <0.001
Inferonasal −0.0003 (−0.006 to 0.005) 0.916 −0.0035 (−0.011 to 0.004) 0.363
Inferonasal × time 0.003 (−0.0001 to 0.005) 0.058 0.002 (−0.001 to 0.006) 0.201
Nasal 0.003 (−0.005 to 0.012) 0.411 0.004 (−0.007 to 0.016) 0.440
Nasal × time 0.005 (0.001 to 0.009) 0.014 0.007 (0.001 to 0.012) 0.014
Superonasal −0.004 (−0.010 to 0.002) 0.177 −0.004 (−0.012 to 0.004) 0.340
Superonasal × time 0.002 (−0.001 to 0.005) 0.140 0.003 (−0.001 to 0.006) 0.134
Model A adjusted for: time, age, interaction age/time, sex, school level, Apolipoprotein ε4, diabetes, diameter of optic nerve head, cataract surgery, and glaucoma.
Model B adjusted for: the same A-model with additional adjustment for axial length (AL) measure.
aAdditional adjustment for the interaction Apolipoprotein ε4/time in model A and B.
MMSE, Mini–Mental State Examination; FCSRT, Free and Cued Selective Reminding Test; RNFL, retinal nerve fiber layer.
Bold p-value indicates p < 0.05.
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takes place within a general elderly population, using a longitu-
dinal design, thus adding complementary knowledge compare 
to previous studies, which are mostly cross-sectional in clinical 
settings.
The association shown in our results was specific to episodic 
memory, which is a cognitive domain strongly implicated in AD 
process. A previous study evaluating the relationship between 
RNFL and cognition also found an association between RNFL 
and episodic memory (word list learning and story recall) among 
participants with normal cognition (26). However, this was a 
cross-sectional study with a small sample size (n = 52).
No association was found with MMSE score, which reflects 
global cognition. However, our population is mainly a well-
functioning population without dementia at baseline; the MMSE 
test may be not sensitive enough to detect subtle changes in the 
early phase of cognitive deterioration (27). Similarly, no correla-
tions between MMSE and peripapillary thickness were found 
in most previous studies comparing peripapillary RNFL in AD 
patients and healthy controls (28, 29). Only 1 previous study 
comparing 35 AD, 35 MCI, and 35 healthy controls reported a 
significant correlation between peripapillary RNFL and MMSE 
in an analysis combining all the participants (30).
More surprisingly, we also found no association with Isaacs’ 
verbal fluency test, even though this test has detected changes 
during very early cognitive decline, as many as 15 years before 
the clinical diagnosis of Alzheimer’s dementia (25). However, 
among elderly people, dementia is the result of several pro-
cesses including neurodegeneration and vascular damage (31). 
Cognitive impairment due to vascular processes is believed to 
preferentially manifest through impaired attention and executive 
function rather than memory function (32). Therefore, verbal 
fluency could reflect the global vascular process more than the 
neurodegenerative process. This may explain the lack of associa-
tion with RNFL thickness, which may be more strongly related to 
neurodegeneration.
Our SD-OCT device automatically calculates RNFL thickness 
both globally and in each of the six segments. This offers the advan-
tage of providing data for the superotemporal and inferotemporal 
segments, which are the thickest zones in the peripapillary area 
and the most sensitive zones to early age-related defects (20, 33). 
As previously reported, the highest RNFL values in our data 
were found in the inferotemporal and superotemporal segments, 
which, together with the temporal segment, are also associated 
with cognitive decline (20).
Our results showing cognitive test alterations reflecting 
episodic memory changes are consistent with previous reports 
stating that the primary degenerative process leading to MCI 
and/or AD is marked by an early deterioration of episodic 
memory (27, 34, 35). In normal elderly subjects, the evaluation 
of this deterioration can even predict the time of progression to 
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MCI as well as the time of progression from MCI to AD (36). 
Furthermore, even though “recall measures” are cited more 
often as good cognitive markers of future AD, “delayed recall 
measures” are excellent predictors of progression to AD (37, 38) 
and can even increase the sensitivity of recall scores used in AD 
identification (39). Therefore, our findings may be relevant to the 
specific brain changes found in the hippocampus and temporal 
regions of people in the preclinical stage of AD (40–42). Previous 
imaging data showing a correlation between RNFL and cerebral 
volumes in the temporal and occipital lobes are concordant with 
these findings (43). In addition to RNFL, future studies should 
explore the ganglion cell-body layer in relationship with cognitive 
performance and brain alteration.
Glaucoma was taken into account in our analyses by adjusting 
for this pathology and by performing sensitivity analyses exclud-
ing participants with glaucoma. Glaucoma is a degenerative 
disease of the optic nerve, and we previously found an increased 
risk of dementia among participants with glaucoma (11). The 
inferotemporal and superotemporal segments are the first seg-
ments damaged in glaucoma. These segments (and the temporal 
segment) are also the ones associated with cognitive decline. 
Therefore, similar neurodegenerative processes could lead to 
both glaucoma and cognitive decline. Axial length was also 
adjusted for in our analyses. However, supplementary analyses 
comparing results with and without adjustment for axial length 
in the subsample of 204 participants with available axial length 
data showed that this adjustment did not materially change our 
results (data not shown); thus, even if axial length is associated 
with RNFL, it seems not confound the relation between RNFL 
and cognition.
Our study has several limitations. First, our follow-up period 
of 2 years may be too short to demonstrate larger effects on other 
cognitive functions. However, to our knowledge, this is the first 
longitudinal study with a large cohort in this field. Second, our 
study included well-functioning subjects who consented to eye 
examination and who therefore may have a lower decline of 
cognitive performance over time than the general population. 
Thus, despite our large study population compared to previous 
case-control studies in this field, we cannot exclude a possible 
lack of power. Third, as race was not available in our cohort, we 
could not adjust for in the analyses; however, our population was 
mostly from a Caucasian origin. Fourth, data on refractive error, 
another ocular variable known to influence RNFL (44) was not 
included in our analyses; but given our findings on axial length 
it is unlikely to have affected results. Finally, as RNFL meas-
urement was not available at the baseline time of the Alienor 
study, the effect of the RNFL evolution over time on cognition 
could not be studied; further follow-ups of our cohort will allow 
studying this.
Our study has some strengths. It is based on a longitudinal 
design with a large population-based cohort including nearly 430 
elderly participants. It includes a systematic eye examination that 
allows the identification and the exclusion of ocular pathologies 
likely to influence RNFL measurement (vitreomacular trac-
tion, myelinated retinal nerve fibers, peripapillary choroidal 
neovascularization, or myopic chorioretinopathy). The OCT 
assessments were performed on the same OCT machine by the 
same experienced technician following a standardized protocol. 
Moreover, the spectral domain technique provided the best quality 
and reproducibility currently available (45). Cognitive functions 
were systematically assessed by trained psychologists blinded to 
ophthalmologic data using standardized procedures and evaluat-
ing several cognitive domains. The association between RNFL 
and delayed episodic memory was found with both RNFL as 
a continuous variable and using the threshold provided by the 
device to classify participants as borderline or outside normal 
limits for RNFL. Finally, numerous potential confounding factors 
were taken into account.
cOnclUsiOn
Our findings enrich the literature on the potential utility of RNFL 
in cognitive deterioration. Although there are still gaps in detailed 
knowledge of the early association between neurodegeneration in 
the retina and in the brain, our findings could lead to the next 
steps of knowledge in that domain. However, these results should 
be corroborated with larger populations and longer follow-ups. 
Moreover, cerebral imaging studies should be implemented 
to better understand the association between retinal and brain 
neurodegeneration.
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